Who
Jeryl L. Hilleman
Director
Company insider
Files Form 4 as: Director, Omada Health; Director, Si-Bone; Director, NovoCure; Director, HilleVax; Director, Cutera; Director, Minerva Neurosciences; Director, Talis Biomedical; Chief Financial Officer, Intersect ENT.
In numbers
- Trades disclosed
- 223
- Buys
- 1
- Sells
- 32
- Bought
- $5,250
- Sold
- $10.2M
- Companies
- 12
- Companies where not an officer
- 8
- First trade
- 15 Feb 2006
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —1,214 at $0.00 | filing |
| 5 Jul 2026filed 20 Jul 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —1,435 at $0.00 | filing |
| 5 Jul 2026filed 20 Jul 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —1,435 at $0.00 | filing |
| 5 Jul 2026filed 7 Jul 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —1,299 at $0.00 | filing |
| 5 Jul 2026filed 7 Jul 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —1,299 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —10,882 at $0.00 | filing |
| 16 Jun 2026filed 18 Jun 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —10,882 at $0.00 | filing |
| 4 Jun 2026filed 9 Jun 2026 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —10,957 at $0.00 | filing |
| 4 Jun 2026filed 9 Jun 2026 | SIBN Si-BoneMedical Devices | SEC FORM 4 Code A | —10,957 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —11,610 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,999 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureoption or derivative · Medical Devices | SEC FORM 4 Code A | —16,999 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Code A | —11,610 at $0.00 | filing |
| 2 Jun 2026filed 3 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $46K2,945 at $15.77 | filing |
| 2 Jun 2026filed 3 Jun 2026 | NVCR NovoCureMedical Devices | SEC FORM 4 Sold | $46K2,945 at $15.77 | filing |
| 5 Apr 2026filed 7 Apr 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —1,544 at $0.00 | filing |
| 5 Apr 2026filed 7 Apr 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —1,544 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —1,601 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —1,601 at $0.00 | filing |
| 5 Oct 2025filed 18 Dec 2025 | OMDA Omada HealthProviders & Facilities | SEC FORM 4 Code A | —1,081 at $0.00 | filing |
News
Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)NVCR · tickerreport.com · 15 Oct 2026NovoCure (NASDAQ:NVCR) and Medline (NASDAQ:MDLN) Financial AnalysisNVCR · themarketsdaily.com · 8 Oct 2026NovoCure (NASDAQ:NVCR) versus Kewaunee Scientific (NASDAQ:KEQU) Head-To-Head ReviewNVCR · dailypolitical.com · 7 Oct 2026
0 headlines in the last 90 days name Jeryl L. Hilleman; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.